Genetic Influence on Toxicity and Prognosis in Women Treated with Breast-Conserving Surgery and Radiation Therapy
Abstract
Women with earlier stage breast cancer who receive breast conserving surgery and radiation therapy have a generally good prognosis. However, among 15-20% of these women, breast cancer recurs, and a similar proportion of women also experience severe toxicity with radiation therapy. It is possible that inter-individual differences in the capability of both tumor and normal cells to protect themselves from radiation-induced damage, and to repair that damage if it does occur, will influence recurrence and toxicity. This variability results from common genetic polymorphisms. This study is conducted in a well-characterized cohort of women who had breast-conserving surgery followed by radiation therapy, and in whom skin reactions were measured and noted. The authors are extracting DNA from blood to determine genetic polymorphisms in a number of genes that may be important in response to treatment. By concluding follow-up on the women in the study, they will be able to determine how variability in genes that protect cells from damage and in those that repair DNA damage will affect both the breast cancer recurrence and toxicity experienced. Follow-up is ongoing through clinic visits, letters, and home visits, and in the next year, they will correlate genotyping results with toxicity.
Document Details
- Document Type
- Technical Report
- Publication Date
- Aug 01, 2005
- Accession Number
- ADA442238
Entities
People
- Christine B. Ambrosone
- Jenny Chang-Claude
Organizations
- Icahn School of Medicine at Mount Sinai